课题基金 / 基金详情

Structural studies of intramembrane protease GlpG

Structural studies of intramembrane protease GlpG
膜内蛋白酶GlpG的结构研究
批准号:
7758329
负责人:
YA HA
金额:
$31.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-02-01 至 2012-01-31

项目摘要

项目成果

YA HA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Intramembrane proteolysis is an important and widespread biochemical mechanism in cell biology: many membrane proteins undergo intramembrane proteolysis to become activated for signal transduction, or to be converted to poorly soluble amyloidal peptides that may cause human disease. The long-term objective of this proposal is to gain a deeper understanding of this mechanism through crystallographic analysis of specific membrane proteins that catalyze the reaction and of their complexes with inhibitors and substrates. Many intramembrane proteases have been recognized as novel and important drug targets for treating infectious and age-related diseases. The current application focuses on GlpG, an E. coli integral membrane protein of the rhomboid serine protease family. Biochemical, mutagenesis and crystallographic experiments are planned to study: (1) how GlpG interacts with class specific inhibitors in order to examine hypothesis that GlpG and other rhomboid proteases use a membrane-embedded Ser-His dyad to directly attack substrate, and to determine features of the protease active site that are important for catalysis; (2) how GlpG interacts with transmembrane substrates through complex structural rearrangements in both proteins, and which factors determine the specificity of this interaction; and (3) the mechanism by which an interesting structural motif regulates protease activity in the membrane. Recent breakthroughs in crystal structure determination of GlpG suggest that this bacterial membrane protein is an excellent model system for studying enzyme action in cell membranes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The biochemical mechanism and pharmacological inhibition of phosphatidylinositol phosphate kinases
  • 批准号:
    10711064
  • 项目类别:
  • 资助金额:
    $32.2万
  • 财政年份:
    2023
  • 负责人:
    YA HA
  • 依托单位:
Development of novel PIP4K inhibitors to treat p53-null cancer
  • 批准号:
    10260471
  • 项目类别:
  • 资助金额:
    $33.88万
  • 财政年份:
    2020
  • 负责人:
    YA HA
  • 依托单位:
Development of novel PIP4K inhibitors to treat p53-null cancer
  • 批准号:
    10427407
  • 项目类别:
  • 资助金额:
    $33.88万
  • 财政年份:
    2020
  • 负责人:
    YA HA
  • 依托单位:
Development of novel PIP4K inhibitors to treat p53-null cancer
  • 批准号:
    10387119
  • 项目类别:
  • 资助金额:
    $5.73万
  • 财政年份:
    2020
  • 负责人:
    YA HA
  • 依托单位:
海外基金